FDA Approves First Treatment For Post-Partum Depression
Source: Fda.gov The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD. “Postpartum depression is a serious condition that, when severe, can be life-threatening. Women may experience thoughts […] Read More